File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Liver transplantation for unresectable colorectal liver metastasis

TitleLiver transplantation for unresectable colorectal liver metastasis
Authors
Issue Date2013
PublisherAME Publishing Company. The Journal's web site is located at http://www.thehbsn.org/
Citation
Hepatobiliary Surgery and Nutrition, 2013, v. 2 n. 3, p. 162-164 How to Cite?
AbstractThe rapid progression in the development of liver transplantation during the last decade is largely attributed by the standardization of operative techniques (1,2) and advances in the pharmacokinetics of immunosuppressive therapy (3). Such improvements in the perioperative management have rendered liver transplantation a safer operation and in turn translated into better long-term survival (4,5). As such, the indication for liver transplantation has been expanded to include malignant liver tumor other than liver cirrhosis. Since the proposal of Milan criteria by Professor Mazzaferro in the late 1990s, liver transplantation has been universally adopted as the curative treatment for early staged hepatocellular carcinoma (HCC) in patients with liver cirrhosis (6). As a result, the 5-year overall survival rate has reached up to 70% in various series (7,8). More importantly, the introduction of Milan criteria has since revolutionized the indications for transplantation and the allocation policy for cadaveric organs.
Persistent Identifierhttp://hdl.handle.net/10722/184752
ISSN

 

DC FieldValueLanguage
dc.contributor.authorChan, Aen_US
dc.date.accessioned2013-07-15T10:07:13Z-
dc.date.available2013-07-15T10:07:13Z-
dc.date.issued2013en_US
dc.identifier.citationHepatobiliary Surgery and Nutrition, 2013, v. 2 n. 3, p. 162-164en_US
dc.identifier.issn2304-3881-
dc.identifier.urihttp://hdl.handle.net/10722/184752-
dc.description.abstractThe rapid progression in the development of liver transplantation during the last decade is largely attributed by the standardization of operative techniques (1,2) and advances in the pharmacokinetics of immunosuppressive therapy (3). Such improvements in the perioperative management have rendered liver transplantation a safer operation and in turn translated into better long-term survival (4,5). As such, the indication for liver transplantation has been expanded to include malignant liver tumor other than liver cirrhosis. Since the proposal of Milan criteria by Professor Mazzaferro in the late 1990s, liver transplantation has been universally adopted as the curative treatment for early staged hepatocellular carcinoma (HCC) in patients with liver cirrhosis (6). As a result, the 5-year overall survival rate has reached up to 70% in various series (7,8). More importantly, the introduction of Milan criteria has since revolutionized the indications for transplantation and the allocation policy for cadaveric organs.-
dc.languageengen_US
dc.publisherAME Publishing Company. The Journal's web site is located at http://www.thehbsn.org/-
dc.relation.ispartofHepatobiliary Surgery and Nutritionen_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleLiver transplantation for unresectable colorectal liver metastasisen_US
dc.typeArticleen_US
dc.identifier.emailChan, A: acchan@hku.hken_US
dc.identifier.authorityChan, ACY=rp00310en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3978/j.issn.2304-3881.2013.05.01-
dc.identifier.hkuros216091en_US
dc.identifier.volume2en_US
dc.identifier.issue3-
dc.identifier.spage162en_US
dc.identifier.epage164en_US
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats